Skip navigationU.S. Food and Drug Administration Center for Drug Evaluation and Research

CDER - Center for Drug Evaluation and Research Logo

Office of Generic Drugs

| CDER Home | Site Info | Comments | What's New |

Reference Listed Drug Labeling Supplements Approved in June 2001

Click on appropriate hyperlink below to view available source document in PDF format.

Approval Date

Product name

Links to source documents

Established Name

NDA No.

Supp. No.

Jun 1

CEFAZOLIN AND DEXTROSE

letter

label

cefazolin for injection/dextrose injection

50-779

S-001

Jun 5

LIMBITROL DS

letter

label

chlordiazepoxide/amitriptyline HCl tablets

16-949

S-033

ZEMURON

letter

label

rocuronium bromide injection

20-214

S-013

Jun 6

MENTAX

letter

label

butenafine HCl cream

20-524

S-005

Jun 8

INTEGRILIN

letter

label

eptifibatide injection

20-718

S-013

LIPITOR

letter

label

atorvastatin calcium tablets

20-702

S-025

NICODERM CQ

letter

  

nicotine transdermal system

20-165

S-019

Jun 11

WELLBUTRIN SR

letter

label

buproprion HCl extended-release tablets

20-358

S-019

Jun 12

COPAXONE

letter

  

glatiramer acetate injection

20-622

S-022

MINIPRESS

letter

label

prazosin HCl capsules

17-442

S-029

PROTONIX

letter

label

pantoprazole sodium delayed-release tablets

20-987

S-001

Jun 13

SEROSTIM

letter

label

somatropin for injection

20-604

S-014

Jun 14

DALMANE

letter

label

flurazepam HCl capsules

16-721

S-074

Jun 15

PRAVACHOL

letter

label

pravastatin sodium tablets

19-898

S-042

Jun 19

EPIVIR

letter

label

lamivudine tablets

lamivudine oral solution

20-564

20-596

S-013

S-014

ORTHO-CEPT

letter

label

desogestrel/ethinyl estradiol tablets

20-301

S-015

Jun 20

ARICEPT

letter

label

donepezil tablets

20-690

S-016

LEUKERAN

letter

label

chlorambucil tablets

10-669

S-024

MIRALAX

letter

label

polyethylene glycol 3350

20-698

S-003

Jun 21

ACCUPRIL

letter

  

quinapril HCl tablets

19-885

S-020

Jun 25

HECTOROL

letter

  

doxercalciferol capsules

20-862

S-001

IMITREX

letter

label

sumatriptan succinate tablets

20-132

S-012

VALTREX

letter

label

valcyclovir HCl tablets

20-550

S-013

VALTREX

letter

label

valcyclovir HCl tablets

20-550

S-012

XENICAL

letter

label

orlistat capsules

20-766

S-007

Jun 26

ORGARAN

letter

  

danaparoid sodium injection

20-430

S-003

Jun 27

ANDROGEL

letter

label

testerone gel

21-015

S-005

CELEXA

letter

  

citalopram HBr tablets

20-822

S-011

Jun 28

FML

letter

label

fluorometholone ophthalmic suspension

16-851

S-051

Jun 29

MINTEZOL

letter

label

thiabendazole tablets

thiabendazole oral suspension

16-096

16-097

S-030

S-024

 totop.gif (1525 bytes)Back to Top   Back Labeling Review Branch Page
FDA/Center for Drug Evaluation and Research
Last Updated: November 01, 200118 Jan 2006 17:16:36 -0500
Originator: OTCOM/DLIS
HTML by JFG